Pure H2O Bio-Technologies, Inc. (Pink Sheets: PRHB) announced today that it has launched it�s first Pilot Program under a Participant Revenue Sharing Agreement (�PRSA�) of its Integrated Hospital Potable Water Disinfection System Model 7000 (the �Unit�). The Company intends to offer qualified individuals or entities (�Participants�) the opportunity to share in revenues generated in its first 100 Hospital Systems for use in related medical facilities.

Under the terms of the Pilot Program, the Company will initially sell up to a total of 100 PRSA�s to qualified Participants. The Participant will pay for the inventory, assembly, related laboratory and microbiologist fees associated with the final certification for the System. Upon the completion of the manufactured Units and its certification with the National Sanitation Foundation (NSF), the Units will be placed in hospitals and other related medical facilities.

Upon the placement of the Units, the Company will pay each Participant an amount equal to 50% from the net proceeds received by the Company from (i) direct purchase agreement(s), (ii) lease agreement(s) or (iii) rental agreement(s). The Company and Participant will share equally from revenues for the full term of one of the above described executed contracts including renewals, but not to exceed the anticipated 10 year life of the Unit.

Mr. Joseph Doxey, President of Pure H2O, stated, "The launch of this program is a major milestone in our Company�s history. With the successful implementation of this Pilot Program, we will have made the transition from a development stage company to a revenue-generating company. Additionally, we will have put the Company in the position of being able to internally fund the manufacture and distribution of our hospital system without the need for outside financing."

Pure H2O recently completed all pre-certification testing of its innovative drinking water treatment system with outstanding results. Pure H2O is ready to complete final certification through the EPA's contractor, National Sanitation Foundation (NSF). Upon completion, the Company will begin additional marketing and sales campaigns. The Company intends to target hospitals, nursing homes and medical facilities in need of pathogen-free and chemical-free water.

The Company will be announcing its progress on a regular basis and will continue to keep its shareholders apprised through these final stages. Visit our web site for updates and to view our production Video at www.pureh20biotech.com.

The foregoing press release contains forward-looking statements that can be identified by such terminology as "expects," "potential," "suggests," "may," "intends," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management's expectations regarding future research, development and/or commercial results could be affected by, among other things, uncertainties relating to the availability of future financing; unexpected regulatory delays or government regulation generally; the company's ability to obtain or maintain patent and other proprietary intellectual property protection; and completion in general. Forward-looking statements speak only as to the date they were made. The company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.

Pure H2O Bio Technologies (CE) (USOTC:PRHB)
Historical Stock Chart
From Jan 2025 to Feb 2025 Click Here for more Pure H2O Bio Technologies (CE) Charts.
Pure H2O Bio Technologies (CE) (USOTC:PRHB)
Historical Stock Chart
From Feb 2024 to Feb 2025 Click Here for more Pure H2O Bio Technologies (CE) Charts.